Who are Lumoptik's investors?

Lumoptik's investors include Beresford Ventures.

How much funding has Lumoptik raised?

Lumoptik has disclosed $1M raised across 2 rounds.

Lumoptik is headquartered in Washington Island, US.

Washington Island, US · Delaware corporation · 1 known investors

Healthtech

Don VerleeMr. Verlee serves as Chief Scientific Officer of the issuer.

Frank LymanNamed on SEC filing

Thomas JanickiNamed on SEC filing

Andy AlexanderNamed on SEC filing

Arthur JanickiMr. Janicki serves as a director of the issuer.

Jeff EnslinMr. Enslin serves as a director of the issuer.

Form D private placements

$1M disclosed across 2 rounds · 2019–2021

▶$900KraisedNov 2021 · 29 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

▶$100KraisedJun 2019 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Who are Lumoptik's investors?: Lumoptik's investors include Beresford Ventures.
How much funding has Lumoptik raised?: Lumoptik has disclosed $1M raised across 2 rounds.
Where is Lumoptik headquartered?: Lumoptik is headquartered in Washington Island, US.